Structural snags frustrate STS for synthetics

Curbs on excess spread and collateral stymie route to ‘high-quality’ signifier

unfinished bridge - Getty.jpg

The quest to restore balance-sheet synthetic securitisations to favour could face an unbridgeable divide for some of Europe’s originators. Regulatory requirements for meeting high-quality labelling status for synthetics – simple, transparent and standardised – come with structural restrictions that could inhibit the potential for market growth.

Market sources say that most deals would not qualify as STS, and while many of the changes needed to attain STS status would be entirely manageable, at

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: